Trial Profile
A prospective, open-label trial to evaluate the ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 30 Dec 2015 New trial record